GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis.
Amanda Littlewood-EvansSophie SarretVerena ApfelPerrine LoesleJanet DawsonJuan ZhangAlban MullerBruno TiganiRainer KneuerSaijel PatelStephanie ValeauxNina GommermannTina Rubic-SchneiderTobias JuntJosé M CarballidoPublished in: The Journal of experimental medicine (2016)
When SUCNR1/GPR91-expressing macrophages are activated by inflammatory signals, they change their metabolism and accumulate succinate. In this study, we show that during this activation, macrophages release succinate into the extracellular milieu. They simultaneously up-regulate GPR91, which functions as an autocrine and paracrine sensor for extracellular succinate to enhance IL-1β production. GPR91-deficient mice lack this metabolic sensor and show reduced macrophage activation and production of IL-1β during antigen-induced arthritis. Succinate is abundant in synovial fluids from rheumatoid arthritis (RA) patients, and these fluids elicit IL-1β release from macrophages in a GPR91-dependent manner. Together, we reveal a GPR91/succinate-dependent feed-forward loop of macrophage activation and propose GPR91 antagonists as novel therapeutic principles to treat RA.
Keyphrases
- rheumatoid arthritis
- fatty acid
- disease activity
- end stage renal disease
- adipose tissue
- oxidative stress
- interstitial lung disease
- ankylosing spondylitis
- chronic kidney disease
- ejection fraction
- newly diagnosed
- single cell
- gene expression
- systemic lupus erythematosus
- peritoneal dialysis
- systemic sclerosis
- genome wide
- stress induced